Irene E.G. van Hellemond

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure

Irene E.G. van Hellemond, Ingeborg J. H. Vriens, Petronella G.M. Peer et al. · JNCI Journal of the National Cancer Institute · 2017 · 31 citations · Full text

Consideration of QRS complex in addition to ST-segment abnormalities in the estimated “risk region” during acute anterior myocardial infarction

Irene E.G. van Hellemond, Sjoerd Bouwmeester, Charles W. Olson et al. · Journal of Electrocardiology · 2011 · 27 citations

Cardiovascular Disease, Myocardial Infarction, Coronary Artery Disease +10

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients

Ingeborg J. H. Vriens, Ashley J.R. De Bie, Maureen J.B. Aarts et al. · Oncotarget · 2017 · 26 citations · Full text

Capecitabine-Associated Terminal Ileitis

Irene E.G. van Hellemond, A.M. Thijs, Geert‐Jan Creemers · Case Reports in Oncology · 2018 · 20 citations · Full text

Oral Fluoropyrimidine, Oncology, Gastrointestinal Oncology +11